Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats

• Published in: Journal of pineal research Vol. 42; no. 2; pp. 138 - 146
• Main Authors: Letechipía-Vallejo, Graciela, López-Loeza, Elisa, Espinoza-González, Verónica, González-Burgos, Ignacio, Olvera-Cortés, María Esther, Moralí, Gabriela, Cervantes, Miguel
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.03.2007; Blackwell
• Subjects: Animals; antioxidant; Biological and medical sciences; Brain Ischemia - drug therapy; Brain Ischemia - pathology; Brain Ischemia - physiopathology; cognitive performance; Fundamental and applied biological sciences. Psychology; global cerebral ischemia; Male; Medical sciences; melatonin; Melatonin - therapeutic use; Neurology; neuroprotection; Neuroprotective Agents - pharmacology; Rats; Vascular diseases and vascular malformations of the nervous system; Vertebrates: endocrinology; Neuroprotection; Nervous system diseases; Melatonin; Rat; Rodentia; Cardiovascular disease; Antioxidant; Long term; Cerebral disorder; Vascular disease; Vertebrata; global cerebral ischemia; Mammalia; Treatment; Animal; Central nervous system disease; Brain ischemia; cognitive performance; Cerebrovascular disease; Pineal hormone
• ISSN: 0742-3098; 1600-079X
• DOI: 10.1111/j.1600-079X.2006.00395.x

:  Consensus on neuroprotection has pointed out the relevance of the long‐term morphological and functional evaluation of the effectiveness of putative neuroprotective procedures. In the present study, place learning (Morris water maze) and working memory (eight‐arm Olton radial maze) were evaluated in adult male rats 90 days after 15 min of global cerebral ischemia (four‐vessel occlusion) followed by continuous i.v. infusion (10 mg/kg/hr) of melatonin (Isch + Mel) or vehicle (Isch + Veh) for 6 hr, and the pyramidal neuron population of the cornus Ammoni (CA) of the hippocampus and layers III and V of the medial prefrontal cortex was assessed at the end of the behavioral testing period (120 days after ischemia). Impairment of place learning, a significant delay in working memory acquisition, and a significant loss of pyramidal neurons in the Ammon's horn (CA1: 23%, CA2: 52% CA3: 73%, hilus: 64% remaining neurons), were observed in the Isch + Veh group. By contrast, a similar performance of the Isch + Mel group to that in the Intact and Sham groups and better than that of the Isch + Veh group, besides a significant reduction of pyramidal neuron loss in the CA subfields (CA1: 79%, CA2: 88% CA3: 86%, hilus: 72% remaining neurons), documented that melatonin treatment led to a long‐term preservation of both the neural substrate, and the capability for integration of spatial learning and memory, mainly dependent on a normal hippocampal functioning. Overall the results emphasize the efficacy of melatonin in counteracting the pathophysiological processes induced by ischemia, by exerting its actions during a short but critical period early after the ischemic episode.